Next-Generation Endocrine Therapies: Opportunities in ER+/HER2- Breast Cancer Care

Get the latest evidence on next-generation endocrine therapies for ER+/HER- breast cancer and optimal strategies for incorporating these agents into clinical practice with an on-demand webcast, downloadable slides, and an expert summary commentary from a live symposium.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca